The overexpression of LOXL2 played a tumor‐promoting role and indicated poor prognosis in esophageal squamous cell carcinoma,16 hepatocellular carcinoma,44, 45 lung carcinoma,17 gastric carcinoma,46 and breast carcinoma.47, 48. This evidence concerns the gene LOXL2 and lung carcinoma.